| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
12,105 |
2,026 |
$461K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,370 |
1,217 |
$150K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
797 |
694 |
$127K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,446 |
1,220 |
$90K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,716 |
1,427 |
$90K |
| 80053 |
Comprehensive metabolic panel |
6,587 |
5,642 |
$89K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,598 |
4,610 |
$81K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
864 |
713 |
$69K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,130 |
7,141 |
$61K |
| 83880 |
|
3,579 |
2,853 |
$59K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,286 |
1,060 |
$54K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,604 |
5,005 |
$50K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,459 |
1,346 |
$49K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
644 |
609 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
748 |
586 |
$35K |
| 84145 |
|
1,864 |
1,517 |
$35K |
| 71045 |
Radiologic examination, chest; single view |
3,015 |
2,660 |
$34K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,760 |
1,335 |
$29K |
| 84484 |
|
2,640 |
2,037 |
$28K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
167 |
156 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,758 |
1,591 |
$23K |
| 97161 |
|
313 |
277 |
$21K |
| 87400 |
|
3,043 |
1,659 |
$20K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
490 |
404 |
$17K |
| 85027 |
|
2,134 |
1,885 |
$17K |
| 84703 |
|
1,435 |
1,313 |
$17K |
| 80061 |
Lipid panel |
1,473 |
1,369 |
$16K |
| 81001 |
|
4,949 |
4,329 |
$15K |
| 83605 |
|
1,008 |
867 |
$14K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,192 |
1,928 |
$14K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
490 |
457 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
160 |
100 |
$12K |
| 86403 |
|
837 |
760 |
$11K |
| 83690 |
|
1,041 |
904 |
$10K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
136 |
121 |
$10K |
| 87070 |
|
1,059 |
946 |
$10K |
| 87040 |
|
653 |
367 |
$8K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
47 |
44 |
$7K |
| 87430 |
|
521 |
496 |
$7K |
| 80305 |
|
642 |
587 |
$7K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
243 |
172 |
$7K |
| 83735 |
|
1,133 |
965 |
$6K |
| 87420 |
|
542 |
510 |
$6K |
| 86756 |
|
327 |
300 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
735 |
706 |
$5K |
| 87076 |
|
892 |
799 |
$5K |
| 87186 |
|
1,030 |
908 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
3,233 |
2,476 |
$4K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
58 |
54 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
161 |
140 |
$3K |
| 94760 |
|
306 |
267 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
541 |
488 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
59 |
40 |
$2K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
13 |
13 |
$2K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
18 |
13 |
$2K |
| 85610 |
|
648 |
526 |
$2K |
| 82607 |
|
94 |
86 |
$2K |
| 85730 |
|
331 |
290 |
$2K |
| G0378 |
Hospital observation service, per hour |
49 |
45 |
$1K |
| 83615 |
|
233 |
202 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
53 |
49 |
$674.14 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
57 |
42 |
$615.68 |
| 71010 |
|
94 |
82 |
$594.00 |
| 97001 |
|
16 |
13 |
$543.84 |
| 93226 |
|
17 |
13 |
$415.00 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
151 |
76 |
$402.44 |
| 73610 |
|
13 |
12 |
$387.39 |
| 85378 |
|
57 |
52 |
$293.82 |
| 80076 |
|
41 |
39 |
$269.09 |
| 93225 |
|
17 |
13 |
$257.82 |
| 84702 |
|
16 |
13 |
$174.85 |
| 82565 |
|
26 |
25 |
$151.10 |
| 93041 |
|
62 |
24 |
$133.74 |
| 73030 |
|
15 |
12 |
$113.57 |
| 83520 |
|
22 |
17 |
$73.96 |
| 82150 |
|
12 |
12 |
$64.82 |
| 82040 |
|
30 |
26 |
$56.64 |
| 81003 |
|
14 |
13 |
$22.40 |
| A9270 |
Non-covered item or service |
665 |
417 |
$10.63 |
| 81015 |
|
15 |
12 |
$4.34 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
44 |
41 |
$0.18 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
94 |
89 |
$0.00 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
26 |
14 |
$0.00 |
| 93000 |
|
81 |
58 |
$0.00 |
| 86769 |
|
32 |
32 |
$0.00 |